We are live on ! Find out more
HUMA icon

Humacyte
HUMA

61 hedge funds and large institutions have $69M invested in Humacyte in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 9

178% more call options, than puts

Call options by funds: $2.68M | Put options by funds: $964K

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

91% more funds holding

Funds holding: 32 → 61 (+29)

2.26% more ownership

Funds ownership: 6.99% → 9.25% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $77.5M → $69M (-$8.53M)

Holders
61
Holders Change
+29
Holders Change %
+90.63%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
39
Increased
10
Reduced
5
Closed
9
Calls
$2.68M
Puts
$964K
Net Calls
+$1.71M
Net Calls Change
-$779K

Top Buyers

1
BlackRock
BlackRock
New York
+$13.9M
2
UOC
UBS O'Connor
Illinois
+$8.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$8.69M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.67M
5
Charles Schwab
Charles Schwab
California
+$2.91M

Top Sellers

1
O
OrbiMed
New York
-$17.4M
2
DCP
Diameter Capital Partners
New York
-$6.47M
3
CH
CVI Holdings
Delaware
-$5.8M
4
MIM
Monashee Investment Management
Massachusetts
-$3.46M
5
MS
Maven Securities
Jersey
-$2.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$21K – – –
ODG
52
O'Dell Group
Ohio
$11K – – –
AWM
53
Avior Wealth Management
Nebraska
$7K – – –
EVM
54
Eaton Vance Management
Massachusetts
$7K +$9.89K +1,000 New
FIA
55
FNY Investment Advisers
New York
$7K +$9.89K +1,000 New
PNC Financial Services Group
56
PNC Financial Services Group
Pennsylvania
$7K +$9.89K +1,000 New
Daiwa Securities Group
57
Daiwa Securities Group
Japan
$2K +$2.98K +301 New
HR
58
Howe & Rusling
New York
$1K – – –
LC
59
Lindbrook Capital
California
$1K +$1.98K +200 New
O
60
OrbiMed
New York
– -$17.4M -1,500,000 Closed
CH
61
CVI Holdings
Delaware
– -$5.8M -500,000 Closed
HF
62
HRT Financial
New York
– -$258K -22,229 Closed
PI
63
PEAK6 Investments
Illinois
– -$213K -18,317 Closed
Kovitz Investment Group Partners
64
Kovitz Investment Group Partners
Illinois
– -$128K -11,050 Closed
Group One Trading
65
Group One Trading
Illinois
– -$61.9K -6,262 Closed
SSB
66
Sandy Spring Bank
Maryland
– -$15K -1,335 Closed
CG
67
Cutler Group
California
– -$9.89K -1,000 Closed
JCM
68
Jacobi Capital Management
Pennsylvania
– -$7K -560 Closed
CFA
69
Carroll Financial Associates
North Carolina
– +$297 +30 New
Royal Bank of Canada
70
Royal Bank of Canada
Ontario, Canada
– +$534 +54 New
1 2
3

HUMA Hedge Fund Activity: Q4 2021 in Review

61 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q4 2021, worth a combined $69M — down 11% from $77.5M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new HUMA positions and 9 closed out — a net gain of 30 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $13.9M. The largest seller was OrbiMed, exiting entirely with an estimated $17.4M sold.

  • 61 institutional investors held Humacyte (HUMA) as of Q4 2021, up from 32 in Q3 2021.
  • Funds reported $69M of Humacyte stock for Q4 2021, down 11% quarter-over-quarter.
  • 39 funds opened new Humacyte positions in Q4 2021 and 9 closed out, a net change of +30 holders.
  • The largest Humacyte buyer in Q4 2021 was BlackRock, an estimated $13.9M added.
  • The largest Humacyte seller in Q4 2021 was OrbiMed, an estimated $17.4M sold.

Based on aggregated 13F filings for Q4 2021.